U.S. Markets closed

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CNDT, BA and BSX

NEW YORK, NY / ACCESSWIRE / May 7, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Conduent Incorporated (CNDT)
Class Period: February 21, 2018 to November 6, 2018
Lead Plaintiff Deadline: May 7, 2019

The complaint alleges that by February 2018, defendants began to represent to investors that Conduent had exited the transformation phase and had cured inefficiencies caused by operating on multiple information resource platforms. However, as demonstrated by defendants' admissions on November 7, 2018, those representations were false, and Conduent remained mired in inadequate technology and third-party agreements that it had been saddled with upon its divestiture from Xerox.

During a November 7, 2018 conference call, CEO Ashok Vemuri stated "we have had continued suboptimal performance from an inherited legacy technology vendor. The performance issues stem from the vendors inability to deliver on service level agreements, lack of responsiveness to Conduent's needs, and poorly structured contracts which we inherited." Vemuri also noted that an "outdated and historically under-invested legacy IT infrastructure has caused major disruptions to our operations and impacted client and delivery performance."

Get additional information about the CNDT lawsuit: http://www.kleinstocklaw.com/pslra-1/conduent-incorporated-loss-submission-form?id=1421&from=1.

The Boeing Company (BA)
Class Period: January 8, 2019 to March 21, 2019
Lead Plaintiff Deadline: June 10, 2019

The complaint alleges that throughout the class period The Boeing Company made materially false and/or misleading statements and/or failed to disclose that: (1) Boeing's 737 MAX airplanes were not as safe as previous models, therefore Boeing included undisclosed "hacks" created by engineering compromises and the lack of safety features which Boeing sold as "optional" add-ons which were designed to help address these safety concerns; (2) most airlines did not purchase these safety "options"; (3) the Federal Aviation Administration granted Boeing its own oversight and certification of Boeing's new flight control system, or Maneuvering Characteristics Augmentation Systems, which was a clear conflict of interest as Boeing was rushing the 737 MAX airplanes to market; and (4) as a result of the foregoing, Boeing's public statement were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Get additional information about the BA lawsuit: http://www.kleinstocklaw.com/pslra-1/the-boeing-company-loss-submission-form-2?id=1421&from=1.

Boston Scientific Corporation (BSX)
Class Period: February 26, 2015 to April 16, 2019
Lead Plaintiff Deadline: June 24, 2019

According to the complaint, Boston Scientific Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Boston Scientific's surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse ("POP") were unsafe; (ii) accordingly, Boston Scientific's continued marketing and sales of these devices in the United States was unlikely to be sustainable; (iii) separately, the Company had sold vaginal mesh implants containing counterfeit or adulterated resin products imported from China; (iv) the foregoing conduct subjected the Company to a heightened risk of regulatory scrutiny and/or government investigations; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Get additional information about the BSX lawsuit: http://www.kleinstocklaw.com/pslra-1/boston-scientific-corporation-loss-submission-form?id=1421&from=1.

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/544520/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CNDT-BA-and-BSX